Share:
Peer-Reviewed Publication
AACE Clin Case Rep2025;11(1):70-74.January 1, 2025Case Reports

Digital Twin Technology in Resolving Polycystic Ovary Syndrome and Improving Metabolic Health: A Comprehensive Case Study.

Paramesh Shamanna1, Anuj Maheshwari2, Ashok Keshavamurthy3, Sanjay Bhat4, Abhijit Kulkarni5, Shivakumar R1, Kumar K1, Mukulesh Gupta6, Mohamed Thajudeen7, Ranjita Kulkarni7, Shashikiran Patil7, Shashank Joshi8
1Bangalore Diabetes Centre, Bangalore, Karnataka, India.
2Shri Hari Kamal Diabetes and Heart Clinic, Lucknow, Uttar Pradesh, India.
3Chandana Clinic, Bangalore, Karnataka, India.
4Department of Cardiology, Mukambika Heart Care, Bangalore, Karnataka, India.
5Department of Cardiology, South End Speciality Clinics, Bangalore, Karnataka, India.
6Udyaan Health Care, Lucknow, Uttar Pradesh, India.
7Twin Health, Mountain View, California.
8Department of Diabetology and Endocrinology, Lilavati Hospital and Research center, Mumbai, India.

Abstract

BACKGROUND: Clinical manifestations of polycystic ovary syndrome (PCOS) are heterogeneous, with hallmarks including anovulation, androgen excess, and insulin resistance. CASE REPORT: A 38-year-old female with typical PCOS features presented with hypertension, obesity, and elevated fasting and postprandial insulin levels. She was enrolled in the Digital Twin (DT) platform, which uses artificial in…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.